INTERMEDIATE DOSE ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ADULT AML

被引：0
|
作者：
JEHN, U [1 ]
KOLB, HJ [1 ]
WILMANNS, W [1 ]
机构：
[1] UNIV MUNICH, MED KLIN 3, D-8000 MUNICH 70, FED REP GER
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] INTERMEDIATE-DOSE ARA-C M-AMSA FOR REMISSION INDUCTION AND HIGH-DOSE ARA-C M-AMSA FOR INTENSIVE CONSOLIDATION IN RELAPSED AND REFRACTORY ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
    JEHN, U
    HEINEMANN, V
    WILMANNS, W
    ANTICANCER RESEARCH, 1989, 9 (01) : 119 - 124
  • [2] ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    LECHNER, K
    SCHWARZINGER, I
    BETTELHEIM, P
    BOGNAR, H
    GEISSLER, K
    HAAS, O
    HINTERBERGER, W
    KOS, M
    LEITHA, T
    NEUMANN, E
    PANZER, S
    POLLAK, C
    BLUT, 1986, 53 (03): : 145 - 145
  • [3] Treatment with high dose Ara-C and Topotecan for relapsed/refractory acute myelogenous leukemia (AML).
    Case, DC
    Ebrahim, KS
    Aronson, FR
    Hedlund, JA
    BLOOD, 2000, 96 (11) : 209B - 209B
  • [4] INTERMEDIATE-DOSE ARA-C AND IDARUBICIN FOLLOWED BY LOW-DOSE ARA-C IS PARTICULARLY EFFECTIVE IN UNMAINTAINED RELAPSED AML
    MUUS, P
    DEWITTE, T
    RAEMAEKERS, J
    BLOOD, 1994, 84 (10) : A146 - A146
  • [5] Idarubicin and standard dose ARA-C (I plus A) for refractory and relapsed adult
    Novik, Y
    Paietta, E
    Dutcher, JP
    Wiernik, PH
    BLOOD, 1999, 94 (10) : 234B - 235B
  • [6] ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [7] A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
    Rosen, PJ
    Rankin, C
    Head, DR
    Boldt, DH
    Luthardt, FW
    Norwood, T
    Pugh, RP
    Karanes, C
    Appelbaum, FR
    LEUKEMIA RESEARCH, 2000, 24 (03) : 183 - 187
  • [8] LOW-DOSE ARA-C AS MAINTENANCE TREATMENT IN AML
    CATALANO, L
    FONTANA, R
    SELLERI, C
    DEROSA, G
    ROTOLI, B
    HAEMATOLOGICA, 1989, 74 (04) : 412 - 413
  • [9] SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE VERSUS HIGH-DOSE ARA-C ALONE IN THE TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LEUKEMIAS
    CAPIZZI, RL
    POWELL, BL
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 40 - 50
  • [10] Intermittent intermediate dose ARA-C as consolidation therapy for AML in the elderly.
    Sperr, WR
    Piribauer, M
    Agis, H
    Mitterbauer, M
    Geissler, K
    Haas, O
    Fonatsch, C
    Jager, U
    Schwarzinger, I
    Thalhammer, F
    Valent, P
    Lechner, K
    BLOOD, 1997, 90 (10) : 2267 - 2267
12345